Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
55.6M
-
Number of holders
-
189
-
Total 13F shares, excl. options
-
60.8M
-
Shares change
-
+1.17M
-
Total reported value, excl. options
-
$9.19B
-
Value change
-
+$195M
-
Put/Call ratio
-
0.99
-
Number of buys
-
109
-
Number of sells
-
-80
-
Price
-
$151.17
Significant Holders of Ascendis Pharma A/S - ADR (ASND) as of Q1 2024
239 filings reported holding ASND - Ascendis Pharma A/S - ADR as of Q1 2024.
Ascendis Pharma A/S - ADR (ASND) has 189 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 60.8M shares
.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (10.1M shares), Artisan Partners Limited Partnership (5.67M shares), FMR LLC (4.94M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (4.08M shares), Avoro Capital Advisors LLC (3.97M shares), JANUS HENDERSON GROUP PLC (3.77M shares), WELLINGTON MANAGEMENT GROUP LLP (2.75M shares), T. Rowe Price Investment Management, Inc. (2.57M shares), Capital International Investors (2.19M shares), and FRANKLIN RESOURCES INC (1.98M shares).
This table shows the top 189 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.